Diabetes and schizophrenia

At a time when the prevalence of type 2 diabetes is increasing at an alarming rate it is becoming increasing clear that patients with severe mental illness including schizophrenia represent a high-risk group for abnormal glucose homeostasis. There is, therefore, a need to raise awareness of the link between diabetes and schizophrenia and provide clear advice and guidance to health care professionals involved in the management of these patients. Copyright © 2005 John Wiley & Sons, Ltd.

[1]  J. Racoosin,et al.  Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement. , 2004, Diabetes care.

[2]  John M Davis,et al.  Physical health monitoring of patients with schizophrenia. , 2004, The American journal of psychiatry.

[3]  Ming T Tsuang,et al.  Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  T. Dinan.  Schizophrenia and diabetes 2003: an expert consensus meeting. Introduction. , 2004, The British journal of psychiatry. Supplement.

[5]  S. Minsky,et al.  Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. , 2004, The Journal of clinical psychiatry.

[6]  T. Dinan.  Stress and the genesis of diabetes mellitus in schizophrenia , 2004, British Journal of Psychiatry.

[7]  R. Holt,et al.  Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia , 2004, British Journal of Psychiatry.

[8]  P. Haddad.  Antipsychotics and diabetes: Review of non-prospective data , 2004, British Journal of Psychiatry.

[9]  J. Thakore,et al.  The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. , 2004, Life sciences.

[10]  S. Chong,et al.  Diabetes Mellitus and Impaired Glucose Tolerance in Patients with Schizophrenia , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[11]  J. Thakore,et al.  Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. , 2003, The American journal of psychiatry.

[12]  H. Meltzer,et al.  −759C/genetic variation of 5HT2C receptor and clozapine-induced weight gain , 2002, The Lancet.

[13]  S. Tsai,et al.  −759C/T genetic variation of 5HT2C receptor and clozapine-induced weight gain , 2002, The Lancet.

[14]  Julie Kreyenbuhl,et al.  Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study , 2002, BMJ : British Medical Journal.

[15]  G. Reynolds,et al.  Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism , 2002, The Lancet.

[16]  B. Barraclough,et al.  Causes of the excess mortality of schizophrenia. , 2000, The British journal of psychiatry : the journal of mental science.

[17]  J. Birtwistle,et al.  The unhealthy lifestyle of people with schizophrenia , 1999, Psychological Medicine.